Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1351-1360 of 1,421) with videos related to

Pageof 143
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium studyAngela Nolin, Morgan D Brown, Samantha M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
The Journal of Clinical Investigation|July 24, 2018
TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndromeIan A Myles, Erik D Anderson, Noah J Earland, et al.
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Acidity across the interface from the ocean surface to sea spray aerosolKyle J Angle, Daniel R Crocker, Rebecca M C Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II StudyKathleen N Moore, Setsuko K Chambers, Erika P Hamilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumorsA Italiano, J R Infante, G I Shapiro, et al.
Gynecologic Oncology|May 12, 2026
Endometriosis and ovarian cancer riskGiorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, et al.
JAMA Surgery|February 16, 2017
Use of Unsolicited Patient Observations to Identify Surgeons With Increased Risk for Postoperative ComplicationsWilliam O Cooper, Oscar Guillamondegui, O Joe Hines, et al.
Lancet (London, England)|February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trialDavid M Gershenson, Austin Miller, William E Brady, et al.
Pageof 143

Showing results (1351-1360 of 1,421) with videos related to

Sort By:
Pageof 143
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium studyAngela Nolin, Morgan D Brown, Samantha M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
The Journal of Clinical Investigation|July 24, 2018
TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndromeIan A Myles, Erik D Anderson, Noah J Earland, et al.
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Acidity across the interface from the ocean surface to sea spray aerosolKyle J Angle, Daniel R Crocker, Rebecca M C Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II StudyKathleen N Moore, Setsuko K Chambers, Erika P Hamilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumorsA Italiano, J R Infante, G I Shapiro, et al.
Gynecologic Oncology|May 12, 2026
Endometriosis and ovarian cancer riskGiorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, et al.
JAMA Surgery|February 16, 2017
Use of Unsolicited Patient Observations to Identify Surgeons With Increased Risk for Postoperative ComplicationsWilliam O Cooper, Oscar Guillamondegui, O Joe Hines, et al.
Lancet (London, England)|February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trialDavid M Gershenson, Austin Miller, William E Brady, et al.
Pageof 143